Rosetta Biosoftware Company Profile

15:30 EDT 18th June 2018 | BioPortfolio

Rosetta Biosoftware develops informatics solutions and provides services that enable research organizations to efficiently and effectively conduct life-saving discoveries and develop drugs. Our mission is to be the premier provider of scalable software solutions to empower research that improves the quality of human life. We provide value to discovery and development efforts by offering customizable informatics solutions and services that are adaptable to your needs. We are a customer-driven organization with the scientific expertise to effectively complement your internal informatics groups or serve as an informatics resource


401 Terry Avenue N
United States of America


Phone: 1 206.926.1200
Fax: 1 206.926.1299

News Articles [19 Associated News Articles listed on BioPortfolio]

Rosetta Genomics Ltd.: Rosetta Announces That Completion of Genoptix Transaction Uncertain

Rosetta Contemplates Bankruptcy Filing May 31, 2018 PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / May 29, 2018 / Rosetta Genomics Ltd. (NASDAQ: ROSG; OTC PINK: ROSGF)(the "Company") announce...

Rosetta Genomics Ltd.: Genoptix Completes Acquisition of PersonalizeDx from Rosetta Genomics

-First step in the process of Genoptix acquiring all of Rosetta Genomics -Next step is the completion of a merger for $8 million in cash pursuant to which value to Rosetta Genomics' equity holders...

Rosetta Genomics Ltd.: Rosetta Announces Resignation of CEO

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / April 10, 2018 / Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and a...

Rosetta Genomics Ltd.: Rosetta Genomics Announces Shareholder Approval of Merger with Genoptix

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / April 26, 2018 / Rosetta Genomics Ltd. (the "Company") (NASDAQ: ROSG) today announced that its shareholders approved a proposed merger with a sub...

$9M Genoptix merger OK'd by Rosetta Genomics shareholders

Genoptix's proposed acquisition of Rosetta Genomics, valued at $9 million, received approval from Rosetta's shareholders.  -More- 

ValuEngine Upgrades Rosetta Genomics (ROSG) to Sell

Separately, Barrington Research cut Rosetta Genomics from an "outperform" rating to a "market perform" rating in a research report on Monday, December 18th. Rosetta Genomics traded down $0.06 during t...

Rosetta Genomics Ltd.: Nasdaq Hearing Panel Determined to Delist Shares of Rosetta Genomics from Nasdaq Stock Market Effective May 22, 2018

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / May 18, 2018 / Rosetta Genomics Ltd. (the "Company") (NASDAQ: ROSG) announced today that on May 18, 2018, it received a decision letter from NASD...

Genoptix plans to acquire Rosetta Genomics for $10mm in cash; transaction later terminated

Oncology diagnostic lab Genoptix Inc. agreed to acquire all outstanding shares of Nasdaq-traded Israeli genomics company Rosetta Genomics Ltd. (cancer diagnostics).

Drugs and Medications [0 Results]


PubMed Articles [21 Associated PubMed Articles listed on BioPortfolio]

Rosetta Protein Structure Prediction from Hydroxyl Radical Protein Footprinting Mass Spectrometry Data.

In recent years mass spectrometry-based covalent labeling techniques such as hydroxyl radical footprinting (HRF) have emerged as valuable structural biology techniques, yielding information on protein...

Combining Rosetta with molecular dynamics (MD): a benchmark of the MD-based ensemble protein design.

Computational protein design is a set of procedures for computing amino acid sequences that will fold into a specified structure. Rosetta Design, a commonly used software for protein design, allows fo...

Modeling the Structure of Helical Assemblies with Experimental Constraints in Rosetta.

Determining high-resolution structures of proteins with helical symmetry can be challenging due to limitations in experimental data. In such instances, structure-based protein simulations driven by ex...

Flex ddG: Rosetta Ensemble-Based Estimation of Changes in Protein-Protein Binding Affinity Upon Mutation.

Computationally modeling changes in binding free energies upon mutation (interface ΔΔG) allows large-scale prediction and perturbation of protein-protein interactions. Additionally, methods that con...

Integrating linear optimization with structural modeling to increase HIV neutralization breadth.

Computational protein design has been successful in modeling fixed backbone proteins in a single conformation. However, when modeling large ensembles of flexible proteins, current methods in protein d...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

RandOmized Study Exploring the Combination of radioTherapy With Two Types of Acupuncture Treatment: The ROSETTA Trial

The ROSETTA-trial will evaluate the effect of acupuncture as a complementary treatment parallel to radiation therapy in oncological patients. The trial is designed as a two-armed trial. De...

Cognitive Brain Training in Older Adults

The investigators will conduct a 8-week proof-of-concept randomized controlled trial to provide preliminary evidence of efficacy of Fit Brains (Rosetta Stone Canada) training -- a mobile c...

Companies [11 Associated Companies listed on BioPortfolio]

Rosetta Biosoftware

Rosetta Biosoftware develops informatics solutions and provides services that enable research organizations to efficiently and effectively conduct life-saving discoveries and develop drugs. Our missio...

rosetta inpharmatics

Rosetta Inpharmatics, a wholly owned subsidiary of Merck & Co. Inc., develops and implements technologies that will improve drug discovery. The company’s leading-edge genomic research and data analy...

Rosetta Genomics Ltd. and Biocept, Inc.

Rosetta develops and commercializes a full range of microRNA-based and other molecular diagnostics. Rosetta’s integrative research platform combining bioinformatics and state...

Rosetta Stone Inc.

Rosetta Stone Inc. is changing the way the world learns languages. Rosetta Stone provides interactive solutions that are acclaimed for the speed and power to unlock the natural la...

Textco BioSoftware, Inc

Textco BioSoftware, Inc. (formerly Textco, Inc.), located in West Lebanon, New Hampshire, has been serving the software needs of molecular biologists for over 20 years - since 1984. Textco's mission i...

More Information about "Rosetta Biosoftware" on BioPortfolio

We have published hundreds of Rosetta Biosoftware news stories on BioPortfolio along with dozens of Rosetta Biosoftware Clinical Trials and PubMed Articles about Rosetta Biosoftware for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rosetta Biosoftware Companies in our database. You can also find out about relevant Rosetta Biosoftware Drugs and Medications on this site too.

Quick Search


Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record